Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
COVID-19 and ethnicity: who will research results apply to?The Lancet (British edition), 2020-06, Vol.395 (10242), p.1955-1957 [Peer Reviewed Journal]2020 Elsevier Ltd ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31380-5 ;PMID: 32539937Full text available |
|
2 |
Material Type: Article
|
The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscapePLoS biology, 2021-04, Vol.19 (4), p.e3000959-e3000959 [Peer Reviewed Journal]2021 Fraser et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Fraser et al 2021 Fraser et al ;ISSN: 1545-7885 ;ISSN: 1544-9173 ;EISSN: 1545-7885 ;DOI: 10.1371/journal.pbio.3000959 ;PMID: 33798194Full text available |
|
3 |
Material Type: Article
|
The impact of the COVID-19 pandemic response on other health researchBulletin of the World Health Organization, 2020-09, Vol.98 (9), p.625-631 [Peer Reviewed Journal](c) 2020 The authors; licensee World Health Organization. ;Copyright World Health Organization Sep 2020 ;(c) 2020 The authors; licensee World Health Organization. 2020 ;ISSN: 0042-9686 ;EISSN: 1564-0604 ;DOI: 10.2471/BLT.20.257485 ;PMID: 33012862Full text available |
|
4 |
Material Type: Article
|
Will COVID-19 be evidence-based medicine's nemesis?PLoS medicine, 2020-06, Vol.17 (6), p.e1003266-e1003266 [Peer Reviewed Journal]COPYRIGHT 2020 Public Library of Science ;COPYRIGHT 2020 Public Library of Science ;This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication: https://creativecommons.org/publicdomain/zero/1.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1549-1676 ;ISSN: 1549-1277 ;EISSN: 1549-1676 ;DOI: 10.1371/journal.pmed.1003266 ;PMID: 32603323Full text available |
|
5 |
Material Type: Article
|
Mapping the situation of research on coronavirus disease-19 (COVID-19): a preliminary bibliometric analysis during the early stage of the outbreakBMC infectious diseases, 2020-08, Vol.20 (1), p.561-8, Article 561 [Peer Reviewed Journal]COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1471-2334 ;EISSN: 1471-2334 ;DOI: 10.1186/s12879-020-05293-z ;PMID: 32738881Full text available |
|
6 |
Material Type: Article
|
Preparedness needs research: How fundamental science and international collaboration accelerated the response to COVID-19PLoS pathogens, 2020-10, Vol.16 (10), p.e1008902-e1008902 [Peer Reviewed Journal]COPYRIGHT 2020 Public Library of Science ;COPYRIGHT 2020 Public Library of Science ;2020 Kinsella et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Kinsella et al 2020 Kinsella et al ;ISSN: 1553-7374 ;ISSN: 1553-7366 ;EISSN: 1553-7374 ;DOI: 10.1371/journal.ppat.1008902 ;PMID: 33035262Full text available |
|
7 |
Material Type: Article
|
Covid-19: What do we know about “long covid”?BMJ (Online), 2020-07, Vol.370, p.m2815-m2815 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2020BMJ ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.m2815Full text available |
|
8 |
Material Type: Article
|
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralizationNature (London), 2021-08, Vol.596 (7871), p.276-280 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Aug 12, 2021 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03777-9 ;PMID: 34237773Full text available |
|
9 |
Material Type: Article
|
A clinical case definition of post-COVID-19 condition by a Delphi consensusThe Lancet infectious diseases, 2022-04, Vol.22 (4), p.e102-e107 [Peer Reviewed Journal]2022 World Health Organization. Published by Elsevier Ltd.All rights reserved ;Copyright © 2022 World Health Organization. Published by Elsevier Ltd.All rights reserved. Published by Elsevier Ltd.. All rights reserved. ;2022. World Health Organization. Published by Elsevier Ltd.All rights reserved ;2022 World Health Organization. Published by Elsevier Ltd.All rights reserved 2022 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(21)00703-9 ;PMID: 34951953Full text available |
|
10 |
Material Type: Article
|
Global impact of the first year of COVID-19 vaccination: a mathematical modelling studyThe Lancet infectious diseases, 2022-09, Vol.22 (9), p.1293-1302 [Peer Reviewed Journal]2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2022. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2022 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(22)00320-6 ;PMID: 35753318Full text available |
|
11 |
Material Type: Article
|
Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19New England Journal of Medicine, 2021-06, Vol.384 (23), p.2259-2261 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2103916 ;PMID: 33822494Digital Resources/Online E-Resources |
|
12 |
Material Type: Article
|
Global cancer research in the post-pandemic worldThe lancet oncology, 2021-12, Vol.22 (12), p.1652-1654 [Peer Reviewed Journal]2021 Elsevier Ltd ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(21)00602-1 ;PMID: 34856137Full text available |
|
13 |
Material Type: Article
|
Heavily mutated Omicron variant puts scientists on alertNature (London), 2021-12, Vol.600 (7887), p.21-21 [Peer Reviewed Journal]Copyright Nature Publishing Group Dec 2, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-021-03552-wFull text available |
|
14 |
Material Type: Article
|
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 VariantNew England Journal of Medicine, 2021-05, Vol.384 (20), p.1899-1909 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2103055 ;PMID: 33951374Digital Resources/Online E-Resources |
|
15 |
Material Type: Article
|
Reboot biomedical R&D in the global public interestNature (London), 2022-02, Vol.602 (7896), p.207-210 [Peer Reviewed Journal]Copyright Nature Publishing Group Feb 10, 2022 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-022-00324-y ;PMID: 35140380Full text available |
|
16 |
Material Type: Article
|
Cytokine StormNew England Journal of Medicine, 2020-12, Vol.383 (23), p.2255-2273 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2020 Massachusetts Medical Society. All rights reserved. 2020 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMra2026131 ;PMID: 33264547Digital Resources/Online E-Resources |
|
17 |
Material Type: Article
|
Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccineNature medicine, 2021-05, Vol.27 (5), p.790-792 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;The Author(s), under exclusive licence to Springer Nature America, Inc. 2021. ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-021-01316-7 ;PMID: 33782619Full text available |
|
18 |
Material Type: Article
|
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in ChinaThe Lancet Oncology, 2020-03, Vol.21 (3), p.335-337 [Peer Reviewed Journal]2020 Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(20)30096-6 ;PMID: 32066541Digital Resources/Online E-Resources |
|
19 |
Material Type: Article
|
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide SettingNew England Journal of Medicine, 2021-09, Vol.385 (12), p.1078-1090 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;COPYRIGHT 2021 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2110475 ;PMID: 34432976Digital Resources/Online E-Resources |
|
20 |
Material Type: Article
|
BEYOND OMICRON: WHAT'S NEXT FOR SARS-COV-2 EVOLUTIONNature (London), 2021-12, Vol.600 (7888), p.204-207 [Peer Reviewed Journal]Copyright Nature Publishing Group Dec 9, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-021-03619-8Full text available |